Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway

The aim of this study was to analyze the role of Ezrin in esophageal squamous cell carcinoma (ESCC) and investigate potential therapeutic targets for ESCC by interfering with Ezrin expression. Bioinformatics analysis revealed that Ezrin expression differed significantly among patients with different...

Full description

Bibliographic Details
Main Authors: Ma Lijuan, Liu Li, Ji Min, Su Liping, Guan Yaling, Xiao Jinling, Pu Hongwei
Format: Article
Language:English
Published: De Gruyter 2023-09-01
Series:Open Life Sciences
Subjects:
Online Access:https://doi.org/10.1515/biol-2022-0743
_version_ 1797668807361167360
author Ma Lijuan
Liu Li
Ji Min
Su Liping
Guan Yaling
Xiao Jinling
Pu Hongwei
author_facet Ma Lijuan
Liu Li
Ji Min
Su Liping
Guan Yaling
Xiao Jinling
Pu Hongwei
author_sort Ma Lijuan
collection DOAJ
description The aim of this study was to analyze the role of Ezrin in esophageal squamous cell carcinoma (ESCC) and investigate potential therapeutic targets for ESCC by interfering with Ezrin expression. Bioinformatics analysis revealed that Ezrin expression differed significantly among patients with different clinical stage ESCC. Moreover, there was a significant correlation between Ezrin and yes-associated protein/connective tissue growth factor (YAP1/CTGF) levels in esophageal cancer. Sixty paraffin-embedded ESCC tissue samples were examined and Ezrin and YAP1/CTGF levels were determined using immunohistochemistry. The positive expression rates of Ezrin and YAP1/CTGF were significantly lower in adjacent tissues than in ESCC tissues. Furthermore, knockdown of Ezrin expression inhibited colony formation and reduced cell migration and invasion. Compared with control ESCC cells, protein expression levels of YAP1 and CTGF were significantly downregulated in cells with Ezrin knocked down. We conclude that Ezrin may be involved in ESCC progression through the Hippo signaling pathway.
first_indexed 2024-03-11T20:34:50Z
format Article
id doaj.art-f684933c26764a8c9b3a79412a983452
institution Directory Open Access Journal
issn 2391-5412
language English
last_indexed 2024-03-11T20:34:50Z
publishDate 2023-09-01
publisher De Gruyter
record_format Article
series Open Life Sciences
spelling doaj.art-f684933c26764a8c9b3a79412a9834522023-10-02T07:37:25ZengDe GruyterOpen Life Sciences2391-54122023-09-011812094910.1515/biol-2022-0743Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathwayMa Lijuan0Liu Li1Ji Min2Su Liping3Guan Yaling4Xiao Jinling5Pu Hongwei6State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Department of Physiology, School of Basic Medical Sciences, Xinjiang Medical University, No. 567, Shangde North Road, Urumqi830017, Xinjiang, ChinaDepartment of Pathology, First Affiliated Hospital, Xinjiang Medical University, No. 137, Liyushan South Road, Urumqi830054, Xinjiang, ChinaDepartment of Pathology, First Affiliated Hospital, Xinjiang Medical University, No. 137, Liyushan South Road, Urumqi830054, Xinjiang, ChinaDepartment of Pathology, First Affiliated Hospital, Xinjiang Medical University, No. 137, Liyushan South Road, Urumqi830054, Xinjiang, ChinaDepartment of Pathology, School of Basic Medical Sciences, Xinjiang Medical University, No. 567, Shangde North Road, Urumqi830017, Xinjiang, ChinaDepartment of Pathology, School of Basic Medical Sciences, Xinjiang Medical University, No. 567, Shangde North Road, Urumqi830017, Xinjiang, ChinaDepartment of Discipline Construction, First Affiliated Hospital, Xinjiang Medical University, No. 137, Liyushan South Road, Urumqi830054, Xinjiang, ChinaThe aim of this study was to analyze the role of Ezrin in esophageal squamous cell carcinoma (ESCC) and investigate potential therapeutic targets for ESCC by interfering with Ezrin expression. Bioinformatics analysis revealed that Ezrin expression differed significantly among patients with different clinical stage ESCC. Moreover, there was a significant correlation between Ezrin and yes-associated protein/connective tissue growth factor (YAP1/CTGF) levels in esophageal cancer. Sixty paraffin-embedded ESCC tissue samples were examined and Ezrin and YAP1/CTGF levels were determined using immunohistochemistry. The positive expression rates of Ezrin and YAP1/CTGF were significantly lower in adjacent tissues than in ESCC tissues. Furthermore, knockdown of Ezrin expression inhibited colony formation and reduced cell migration and invasion. Compared with control ESCC cells, protein expression levels of YAP1 and CTGF were significantly downregulated in cells with Ezrin knocked down. We conclude that Ezrin may be involved in ESCC progression through the Hippo signaling pathway.https://doi.org/10.1515/biol-2022-0743esophageal squamous cell carcinomaezrinyes-associated proteinhippo signaling pathwayconnective tissue growth factor
spellingShingle Ma Lijuan
Liu Li
Ji Min
Su Liping
Guan Yaling
Xiao Jinling
Pu Hongwei
Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
Open Life Sciences
esophageal squamous cell carcinoma
ezrin
yes-associated protein
hippo signaling pathway
connective tissue growth factor
title Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
title_full Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
title_fullStr Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
title_full_unstemmed Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
title_short Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
title_sort ezrin promotes esophageal squamous cell carcinoma progression via the hippo signaling pathway
topic esophageal squamous cell carcinoma
ezrin
yes-associated protein
hippo signaling pathway
connective tissue growth factor
url https://doi.org/10.1515/biol-2022-0743
work_keys_str_mv AT malijuan ezrinpromotesesophagealsquamouscellcarcinomaprogressionviathehipposignalingpathway
AT liuli ezrinpromotesesophagealsquamouscellcarcinomaprogressionviathehipposignalingpathway
AT jimin ezrinpromotesesophagealsquamouscellcarcinomaprogressionviathehipposignalingpathway
AT suliping ezrinpromotesesophagealsquamouscellcarcinomaprogressionviathehipposignalingpathway
AT guanyaling ezrinpromotesesophagealsquamouscellcarcinomaprogressionviathehipposignalingpathway
AT xiaojinling ezrinpromotesesophagealsquamouscellcarcinomaprogressionviathehipposignalingpathway
AT puhongwei ezrinpromotesesophagealsquamouscellcarcinomaprogressionviathehipposignalingpathway